Novo Nordisk (Denmark)
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Novo Nordisk (Denmark), Denmark, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
59%
Total
Publications
12K
Total Open
Publications
7K
Total
Citations
505K
Open Access
Percentage
59%
Total
Publications
12K
Total Open
Publications
7K
Total
Citations
505K
Breakdown
Publisher Open
17%
Both
31%
Other Platform Open
11%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 41%
2.3K
Hybrid 29%
1.6K
No Guarantees 30%
1.7K
Other Platform Open
Domain 61%
3.1K
Institution 51%
2.6K
Preprint 18%
927
Other Internet 12%
607
Public 4%
198
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 3.1K |
doaj.org OAI-PMH Repository | Institution | 1K |
University of Copenhagen | Institution | 777 |
arXiv | Preprint | 504 |
DOI | Other Internet | 416 |
Unknown Repository | Other Internet | 307 |
Technical University of Denmark | Institution | 250 |
bioRxiv | Preprint | 235 |
Figshare | Public | 190 |
Europe PMC | Domain | 131 |